Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Ophthalmology · Aniridia

Managing Aniridia Over a Lifetime: Treatments and Interventions

At a Glance

Managing aniridia requires a careful balance of daily protection and safe medical interventions. Essential strategies include using preservative-free eye drops, wearing UV-protective lenses, and avoiding high-risk procedures like artificial iris implants to protect the eye's fragile structures.

Managing aniridia is a lifelong journey of protection and proactive care. While the condition is complex, modern medicine offers a wide array of tools to help maintain vision and keep your child comfortable. The goal of a long-term care plan is to balance the need for intervention with the preservation of the eye’s delicate structures [1][2].

1. Daily Protection and Optimization

The most important “treatment” begins with simple, daily habits that shield the eyes from strain and damage.

  • UV Protection: Because the iris cannot block out bright light, extreme light sensitivity (photophobia) is common [3]. Specialized UV-filtering sunglasses (often with specific tints like amber or gray) and wide-brimmed hats are essential from infancy [4][5].
  • Refractive Correction: Most children with aniridia will need glasses to correct for nearsightedness, farsightedness, or astigmatism. These glasses can be made with photochromic lenses (which darken in sunlight) to provide both clarity and protection [3].

2. Managing the Ocular Surface (AAK)

To delay the progression of Aniridia-Associated Keratopathy (AAK), the primary goal is to keep the corneal surface healthy and lubricated [6].

  • Preservative-Free Drops: Standard eye drops often contain preservatives (like BAK) that can be toxic to the fragile corneal cells in aniridia. Only preservative-free lubricants should be used [7][8].
  • Advanced Biological Drops: If standard drops are not enough, doctors may use PRGF (Plasma Rich in Growth Factors) or Autologous Serum. These are specialized, safe drops created from a small sample of the patient’s own blood. They contain natural healing factors that support the fragile corneal surface far better than artificial tears [9][10].
  • Avoiding Traditional Transplants: Standard corneal transplants (keratoplasty) are often high-risk in aniridia because the underlying problem is a lack of stem cells. Instead, specialized limbal stem cell transplants may be considered for advanced cases [11][12].

3. The Challenge of Glaucoma

Glaucoma is one of the most significant threats to long-term vision in aniridia [2].

  • Medical Therapy: Doctors typically start with eye drops to lower internal eye pressure. As with lubricants, these should ideally be preservative-free to protect the cornea.
  • Surgical Interventions: If medications fail, surgical options like Glaucoma Drainage Devices (GDD) (a small tube to drain fluid) or trabeculectomy may be used [13][14]. These surgeries are “tricky” because they can sometimes accelerate corneal clouding, requiring a careful, expert approach [15].

4. Cataract Surgery: A Delicate Balance

Most people with aniridia will eventually develop cataracts [2]. While surgery to remove the cloudy lens can significantly improve vision, it is often a “double-edged sword.”

  • The Risk: Any surgery inside the eye can potentially worsen glaucoma or AAK [15].
  • The Strategy: Surgeons often wait until the cataract is causing a significant functional disability before operating.
  • A Warning on Artificial Iris Implants: While “artificial iris implants” exist, they are widely considered contraindicated (highly dangerous) for congenital aniridia. They can severely exacerbate glaucoma, damage the fragile drainage angle, and accelerate corneal failure (AAK) [15][16]. Post-surgical light sensitivity is typically managed much more safely with conservative measures like tinted spectacles, photochromic lenses, or specialized custom contact lenses [5].

5. Empowering Your Child: Low-Vision Support

Vision impairment does not have to limit a child’s potential. Low-vision aids are critical tools for independence [17][18].

  • Tools: Support can range from handheld magnifiers, high-contrast materials, and special lighting for toddlers, to digital video magnifiers and screen-reading software as they grow.
  • Early Intervention & School Support: In many regions, early intervention specialists can work with your child from infancy to support developmental milestones. As your child enters school, they will likely qualify for an Individualized Education Program (IEP) or a 504 Plan (or your region’s equivalent). These formal plans ensure accommodations—like preferential seating in class, specialized tablets, and extended time for testing—are legally provided [19].

By working with a multidisciplinary team and focusing on protective care, you can help your child navigate the challenges of aniridia and maximize their visual potential throughout their life [1][16].

Common questions in this guide

What are the best eye drops for aniridia?
People with aniridia should only use preservative-free eye drops. Standard drops containing preservatives can damage fragile corneal cells. For advanced cases, doctors may recommend specialized biological drops like PRGF or autologous serum made from the patient's own blood.
Is an artificial iris implant safe for congenital aniridia?
No, artificial iris implants are highly dangerous for patients with congenital aniridia. They can severely worsen glaucoma and accelerate corneal failure, making tinted glasses or custom contact lenses a much safer option for managing light sensitivity.
When should my child have cataract surgery for aniridia?
Surgeons typically wait until the cataract causes significant vision problems before operating. This is because any surgery inside an eye with aniridia carries a high risk of worsening existing glaucoma or corneal disease.
How can I protect my child's eyes from extreme light sensitivity?
Daily use of UV-filtering sunglasses with specific tints like amber or gray, along with wide-brimmed hats, is essential from infancy. Photochromic lenses that darken in the sun can also provide both clear vision and light protection.
What kind of school support can a child with aniridia receive?
Children with visual impairments often qualify for an Individualized Education Program (IEP) or a 504 Plan. These legally ensure school accommodations like special tablets, preferential seating, and extended testing time to help them succeed.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given the high risk of surgery, at what point do we decide that the benefit of removing a cataract outweighs the risk to my child's cornea and eye pressure?
  2. 2.What is your experience with PRGF (Plasma Rich in Growth Factors) for AAK, and should we consider it if preservative-free drops aren't enough?
  3. 3.Which type of glaucoma surgery do you recommend if medications are no longer sufficient, and why?
  4. 4.Can you provide a referral for an early intervention specialist who specifically works with children with visual impairments?
  5. 5.What specific UV-protective filters (tint color and percentage) would be most beneficial for my child's light sensitivity?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Congenital aniridia: European COST action ANIRIDIA-NET guidelines for diagnosis, management and care.

    Romano D, Romano V, Daruich A, et al.

    Acta ophthalmologica 2026; (104(3)):267-279 doi:10.1111/aos.17587.

    PMID: 40892309
  2. 2

    [Glaucoma in PAX6-related congenital aniridia: A review of the literature].

    Bastelica P, Daruich A, Paganelli B, et al.

    Journal francais d'ophtalmologie 2025; (48(1)):104300 doi:10.1016/j.jfo.2024.104300.

    PMID: 39368260
  3. 3

    [Congenital aniridia in children].

    Bremond-Gignac D

    La Revue du praticien 2019; (69(1)):67-70.

    PMID: 30983291
  4. 4

    Congenital aniridia with cataract: case series.

    Wang JD, Zhang JS, Xiong Y, et al.

    BMC ophthalmology 2017; (17(1)):115 doi:10.1186/s12886-017-0503-6.

    PMID: 28676040
  5. 5

    Long-term follow-up of a custom-made prosthetic iris device in patients with congenital aniridia.

    Figueiredo GB, Snyder ME

    Journal of cataract and refractive surgery 2020; (46(6)):879-887 doi:10.1097/j.jcrs.0000000000000175.

    PMID: 32176163
  6. 6

    Corneal Abnormalities in Congenital Aniridia: Congenital Central Corneal Opacity Versus Aniridia-associated Keratopathy.

    Lee HK, Kim MK, Oh JY

    American journal of ophthalmology 2018; (185()):75-80 doi:10.1016/j.ajo.2017.10.017.

    PMID: 29101006
  7. 7

    Effect of Silica in the Manufacture of Autologous Serum Eye Drops on Corneal Stromal Cells.

    Kim S, Lee JE

    Cornea 2024; (43(3)):372-377 doi:10.1097/ICO.0000000000003412.

    PMID: 38015940
  8. 8

    Five-Year Risk and Safety Profile of Autologous Serum Eye Drop Therapy.

    Sanak F, Iselin K, Job O, et al.

    Klinische Monatsblatter fur Augenheilkunde 2024; (241(4)):388-391 doi:10.1055/a-2244-6285.

    PMID: 38653292
  9. 9

    Beneficial Effects of Plasma Rich in Growth Factors (PRGF) Versus Autologous Serum and Topical Insulin in Ocular Surface Cells.

    Anitua E, de la Fuente M, Sánchez-Ávila RM, et al.

    Current eye research 2023; (48(5)):456-464 doi:10.1080/02713683.2023.2173237.

    PMID: 36695530
  10. 10

    Treatment of Corneal Epithelium Lesions with Plasma Rich in Growth Factors: A Case Series and Implications.

    Ortiz F, Cárcamo S, Souza-Mello V, et al.

    Healthcare (Basel, Switzerland) 2025; (13(17)) doi:10.3390/healthcare13172184.

    PMID: 40941535
  11. 11

    Management of Congenital Aniridia-Associated Keratopathy: Long-Term Outcomes from a Tertiary Referral Center.

    Yazdanpanah G, Bohm KJ, Hassan OM, et al.

    American journal of ophthalmology 2020; (210()):8-18 doi:10.1016/j.ajo.2019.11.003.

    PMID: 31730836
  12. 12

    [Staging of aniridia-associated keratopathy].

    Náray A, Fries FN, Csidey M, et al.

    Orvosi hetilap 2023; (164(27)):1063-1069 doi:10.1556/650.2023.32803.

    PMID: 37422887
  13. 13

    Ahmed Glaucoma Valve in Aniridia.

    Ahmed AA, Netland PA

    Clinical ophthalmology (Auckland, N.Z.) 2025; (19()):2487-2493 doi:10.2147/OPTH.S531997.

    PMID: 40761530
  14. 14

    Outcomes of Trabeculectomy and Glaucoma Drainage Device Surgery in Congenital Aniridia-Associated Glaucoma: A Systematic Review and Meta-Analysis.

    Tóth G, Liu S, Li S, et al.

    Ophthalmology and therapy 2025; (14(10)):2323-2343 doi:10.1007/s40123-025-01215-x.

    PMID: 40736869
  15. 15

    The Effect of Lens Properties on Visual Acuity, Aniridia Associated Keratopathy and Secondary Glaucoma in Congenital Aniridia Subjects.

    Náray A, Fries FN, Munteanu C, et al.

    Current eye research 2025; (50(4)):381-393 doi:10.1080/02713683.2024.2438687.

    PMID: 39687987
  16. 16

    Clinical outcomes and visual prognostic factors in congenital aniridia.

    Jacobson A, Mian SI, Bohnsack BL

    BMC ophthalmology 2022; (22(1)):235 doi:10.1186/s12886-022-02460-5.

    PMID: 35614435
  17. 17

    [Congenital aniridia patients' experience on their visual impairment in Hungary.]

    Csidey M, Grupcheva C, Stachon T, et al.

    Orvosi hetilap 2023; (164(34)):1342-1349 doi:10.1556/650.2023.32845.

    PMID: 37634154
  18. 18

    Standardized Assessment of Health-Related Quality of Life in Patients with Congenital Aniridia.

    Hoxha Z, Fries FN, Hecker D, et al.

    Klinische Monatsblatter fur Augenheilkunde 2025; (242(3)):228-239 doi:10.1055/a-2463-3879.

    PMID: 39694046
  19. 19

    Exploring the human experience of congenital aniridia: A narrative medicine approach.

    Ancona C, Marini MG, Minetti F, et al.

    European journal of ophthalmology 2026; (36(3)):601-608 doi:10.1177/11206721251407851.

    PMID: 41400928

This page provides general information about long-term aniridia management and treatments. It does not replace professional medical advice from a pediatric ophthalmologist regarding your child's specific care plan.

Get notified when new evidence is published on Isolated aniridia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.